References
- Simmons ML, Lamborn KR, Takahashi M, et al. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 2001;61:1122-1128
- Senger D, Cairncross JG, Forsyth PA. Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype? Cancer J 2003;9:214-221 https://doi.org/10.1097/00130404-200305000-00009
- Shaw EG, Seiferheld W, Scott C, et al. Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients. Int J Radiat Oncol Biol Phys 2003;57:S135-136
- Curran WJ, Jr, Scott CB, Horton J, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993;85:704-710 https://doi.org/10.1093/jnci/85.9.704
- Walker MD, Strike TA, Sheline GE. An analysis of doseeffect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-1731 https://doi.org/10.1016/0360-3016(79)90553-4
- Andersen AP. Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol 1978;17:475-484 https://doi.org/10.3109/02841867809128178
- Kristiansen K, Hagen S, Kollevold T, et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981;47:649-652 https://doi.org/10.1002/1097-0142(19810215)47:4<649::AID-CNCR2820470405>3.0.CO;2-W
- Shapiro WR, Young DF. Treatment of malignant glioma. A controlled study of chemotherapy and irradiation. Arch Neurol 1976;33:494-450 https://doi.org/10.1001/archneur.1976.00500070036007
- Sandberg-Wollheim M, Malmstrom P, Stromblad LG, et al. A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 1991; 68:22-29 https://doi.org/10.1002/1097-0142(19910701)68:1<22::AID-CNCR2820680105>3.0.CO;2-2
- Walker MD, Alexander E, Jr., Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978; 49:333-343
- Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980; 303:1323-1329 https://doi.org/10.1056/NEJM198012043032303
- Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001; 95:190-198 https://doi.org/10.3171/jns.2001.95.2.0190
- Nazzaro JM, Neuwelt EA. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 1990;73:331-344 https://doi.org/10.3171/jns.1990.73.3.0331
- Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 1991;64:769-774 https://doi.org/10.1038/bjc.1991.396
- Nelson DF, Diener-West M, Horton J, Chang CH, Schoenfeld D, Nelson JS. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group. NCI Monogr 1988:279-284
- Nwokedi EC, DiBiase SJ, Jabbour S, Herman J, Amin P, Chin LS. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 2002; 50: 41-46; discussion 46-47 https://doi.org/10.1097/00006123-200201000-00009
- Curran WJ, Jr., Scott CB, Weinstein AS, et al. Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 1993;11:857-862 https://doi.org/10.1200/JCO.1993.11.5.857
- Shapiro WR, Green SB, Burger PC, et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989;71:1-9 https://doi.org/10.3171/jns.1989.71.1.0001
- Nakagawa K, Aoki Y, Fujimaki T, et al. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998;40:1141-1149 https://doi.org/10.1016/S0360-3016(97)00911-5
- Payne DG, Simpson WJ, Keen C, Platts ME. Malignant astrocytoma: hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial. Cancer 1982;50:2301-2306 https://doi.org/10.1002/1097-0142(19821201)50:11<2301::AID-CNCR2820501114>3.0.CO;2-J
- hin KH, Muller PJ, Geggie PH. Superfractionation radiation therapy in the treatment of malignant astrocytoma. Cancer 1983;52:2040-2043 https://doi.org/10.1002/1097-0142(19831201)52:11<2040::AID-CNCR2820521112>3.0.CO;2-K
- hin KH, Urtasun RC, Fulton D, et al. Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer 1985;56:758-760 https://doi.org/10.1002/1097-0142(19850815)56:4<758::AID-CNCR2820560410>3.0.CO;2-2
- Deutsch M, Green SB, Strike TA, et al. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Radiat Oncol Biol Phys 1989;16:1389-1396 https://doi.org/10.1016/0360-3016(89)90939-5
- Ludgate CM, Douglas BG, Dixon PF, Steinbok P, Jackson SM, Goodman GB. Superfractionated radiotherapy in grade III, IV intracranial gliomas. Int J Radiat Oncol Biol Phys 1988;15:1091-1095 https://doi.org/10.1016/0360-3016(88)90189-7
- Horiot JC, van den Bogaert W, Ang KK, et al. European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey. Front Radiat Ther Oncol 1988;22:149-161
- Werner-Wasik M, Scott CB, Nelson DF, et al. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 1996;77:1535-1543 https://doi.org/10.1002/(SICI)1097-0142(19960415)77:8<1535::AID-CNCR17>3.0.CO;2-0
- Griffin TW, Davis R, Laramore G, et al. Fast neutron radiation therapy for glioblastoma multiforme. Results of an RTOG study. Am J Clin Oncol 1983;6:661-667 https://doi.org/10.1097/00000421-198312000-00009
- Duncan W, McLelland J, Jack WJ, et al. Report of a randomised pilot study of the treatment of patients with supratentorial gliomas using neutron irradiation. Br J Radiol 1986;59:373-377 https://doi.org/10.1259/0007-1285-59-700-373
- Duncan W, McLelland J, Jack WJ, et al. The results of a randomised trial of mixed-schedule (neutron/photon) irradiation in the treatment of supratentorial Grade III and Grade IV astrocytoma. Br J Radiol 1986;59:379-383 https://doi.org/10.1259/0007-1285-59-700-379
- Laramore GE, Diener-West M, Griffin TW, et al. Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1988;14: 1093-1102 https://doi.org/10.1016/0360-3016(88)90384-7
- Pickles T, Goodman GB, Rheaume DE, et al. Pion radiation for high grade astrocytoma: results of a randomized study. Int J Radiat Oncol Biol Phys 1997;37:491-497 https://doi.org/10.1016/S0360-3016(96)00542-1
- Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study. Eur J Cancer Clin Oncol 1983;19:39-42
- MRC. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas. A report from the MRC Working Party on misonidazole in gliomas. Br J Radiol 1983;56:673-682 https://doi.org/10.1259/0007-1285-56-669-673
- MRCT. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol 2001; 19:509-518 https://doi.org/10.1200/JCO.2001.19.2.509
- Stupp R, Dietrich PY, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002;20:1375-1382 https://doi.org/10.1200/JCO.20.5.1375
- Selker RG, Shapiro WR, Burger P, et al. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 2002;51:343-355; discussion 355-347 https://doi.org/10.1097/00006123-200208000-00009
- Laperriere NJ, Leung PM, McKenzie S, et al. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 1998;41:1005-1011 https://doi.org/10.1016/S0360-3016(98)00159-X
- Lee SW, Kim GE, Suh CO, Kim WC, Keum KC, Chang SK. Analysis of Prognostic Factors in Glioblastoma Multiforme.J Korean Soc Ther Radiol Oncol 1996;14:181-190
- Diete S, Treuheit T, Dietzmann K, Schmidt U, Wallesch CW. Sex differences in length of survival with malignant astrocytoma, but not with glioblastoma. J Neurooncol 2001;53:47-49 https://doi.org/10.1023/A:1011849411227
- Reavey-Cantwell JF, Haroun RI, Zahurak M, et al. The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature. J Neurooncol 2001;55:195-204 https://doi.org/10.1023/A:1013845004294
- Verzat C, Delisle MB, Courriere P, Hollande E. Influence of host sex on the growth of a human glioblastoma line in athymic mice. Neuropathol Appl Neurobiol 1990;16: 41-151